Cefle A - Search Results

1

Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-α Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence.

Kisacik B, Pamuk ON, Onat AM, Erer SB, Hatemi G, Ozguler Y, Pehlivan Y, Kilic L, Ertenli I, Can M, Direskeneli H, Keser G, Oksel F, Dalkilic E, Yilmaz S, Pay S, Balkarli A, Cobankara V, Cetin GY, Sayarlioglu M, Cefle A, Yazici A, Avci AB, Terzioglu E, Ozbek S, Akar S, Gul A. Kisacik B, et al. Among authors: cefle a. J Rheumatol. 2016 Mar;43(3):524-9. doi: 10.3899/jrheum.150177. Epub 2016 Jan 15. J Rheumatol. 2016. PMID: 26773107

2

A patient with classical polyarteritis nodosa evolving into end stage renal failure.

Kamali S, Gul A, Poyanli A, Cefle A, Sayarlioglu M, Inanc M, Aral O, Konice M. Kamali S, et al. Among authors: cefle a. Ren Fail. 2003 Nov;25(6):1037-41. doi: 10.1081/jdi-120026039. Ren Fail. 2003. PMID: 14669863 Free article.

3

Expression of KIR and C-type lectin receptors in Behcet's disease.

Saruhan-Direskeneli G, Uyar FA, Cefle A, Onder SC, Eksioglu-Demiralp E, Kamali S, Inanç M, Ocal L, Gül A. Saruhan-Direskeneli G, et al. Among authors: cefle a. Rheumatology (Oxford). 2004 Apr;43(4):423-7. doi: 10.1093/rheumatology/keh063. Epub 2003 Dec 16. Rheumatology (Oxford). 2004. PMID: 14679294

4

Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases.

Kamali S, Cefle A, Sayarlioglu M, Gul A, Inanc M, Ocal L, Aral O, Konice M. Kamali S, et al. Among authors: cefle a. Rheumatol Int. 2005 Apr;25(3):211-4. doi: 10.1007/s00296-003-0422-0. Epub 2004 Jan 14. Rheumatol Int. 2005. PMID: 14722731

5

Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization.

Sayarlioglu M, Inanc M, Kamali S, Cefle A, Karaman O, Gul A, Ocal L, Aral O, Konice M. Sayarlioglu M, et al. Among authors: cefle a. Lupus. 2004;13(4):274-8. doi: 10.1191/0961203303lu529xx. Lupus. 2004. PMID: 15176665

6

A comparison of clinical findings of familial Mediterranean fever patients with and without amyloidosis.

Cefle A, Kamali S, Sayarlioglu M, Inanc M, Ocal L, Aral O, Konice M, Gul A. Cefle A, et al. Rheumatol Int. 2005 Aug;25(6):442-6. doi: 10.1007/s00296-004-0471-z. Epub 2004 Jul 30. Rheumatol Int. 2005. PMID: 15290087

7

Necrotizing crescentic glomerulonephritis with granulomatous vasculitis in a patient with familial Mediterranean fever and renal amyloidosis.

Cefle A, Kilicaslan I, Gul A, Kamali S, Inanc M, Konice M. Cefle A, et al. Clin Exp Rheumatol. 2004 Jul-Aug;22(4 Suppl 34):80. Clin Exp Rheumatol. 2004. PMID: 15515794 No abstract available.

8

Characteristics of patients with late onset systemic lupus erythematosus in Turkey.

Sayarlioglu M, Cefle A, Kamali S, Gul A, Inanc M, Ocal L, Aral O, Konice M. Sayarlioglu M, et al. Among authors: cefle a. Int J Clin Pract. 2005 Feb;59(2):183-7. doi: 10.1111/j.1742-1241.2004.00283.x. Int J Clin Pract. 2005. PMID: 15854194

9

Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases.

Sayarlioglu M, Cefle A, Inanc M, Kamali S, Dalkilic E, Gul A, Ocal L, Aral O, Konice M. Sayarlioglu M, et al. Among authors: cefle a. Int J Clin Pract. 2005 Feb;59(2):202-5. doi: 10.1111/j.1742-1241.2004.00294.x. Int J Clin Pract. 2005. PMID: 15854197

10

Risk of cancer in Turkish patients after treatment with TNF antagonists.

Pay S; Society for Research and Education in Rheumatology of Turkey. Pay S, et al. Rheumatology (Oxford). 2008 Apr;47(4):548-9. doi: 10.1093/rheumatology/ken026. Epub 2008 Feb 23. Rheumatology (Oxford). 2008. PMID: 18296720 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters